The Korean Journal of Medicine

  • 제81권2호
  • /
  • Pages.190-192
  • /
  • 2011
  • /
  • 1738-9364(pISSN)
  • /
  • 2289-0769(eISSN)
대한내과학회 (The Korean Association of Internal Medicine)
권호 표지

내시경 유두 괄약근 절개술과 아스피린

Endoscopic Sphincterotomy and Aspirin

  • 이종균 (성균관대학교 의과대학 삼성서울병원 소화기내과)
  • Lee, Jong-Kyun (Division of Gastroenterology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine)
  • 발행 : 2011.08.01
⟨ 이전 논문 다음 논문 ⟩

초록

Antiplatelet drugs are associated with gastro-intestinal bleedings. Aspirin is one of most popular medicines for cardiovascular diseases. Endoscopic sphincterotomy (EST) has a high procedural risk of bleeding. However, there has been no evidence-based study about taking aspirin before and after EST. There are controversies in the guidelines from American Society for Gastrointestinal Endoscopy, British Society of Gastroenterology, and Japan Gastroenterological Endoscopy Society. Continuous intake of aspirin before EST is recommended in Western guidelines. To the contrary, 3 to 7 days cessation of aspirin before EST is needed according to Japan guidelines. Until a well-organized study make definite evidence, personalized approach is prudent to decide to stop or continue to take aspirin before and after EST.

키워드

참고문헌

  1. Cotton PB, Lehman G, Vennes J, et al. Endoscopic sphincterotomy complications and their management: an attempt at consensus. Gastrointest Endosc 1991;37:383-393. https://doi.org/10.1016/S0016-5107(91)70740-2
  2. Nelson DB, Freeman ML. Major hemorrhage from endoscopic sphincterotomy: risk factor analysis. J Clin Gastroenterol 1994;19:283-287. https://doi.org/10.1097/00004836-199412000-00004
  3. Vaira D, D'Anna L, Ainley C, et al. Endoscopic sphincterotomy in 1000 consecutive patients. Lancet 1989;2:431-434.
  4. Andriulli A, Loperfido S, Napolitano G, et al. Incidence rates of post-ERCP complications: a systematic survey of prospective studies. Am J Gastroenterol 2007;102:1781-1788. https://doi.org/10.1111/j.1572-0241.2007.01279.x
  5. Freeman ML. Complications of endoscopic biliary sphincterotomy: a review. Endoscopy 1997;29:288-297. https://doi.org/10.1055/s-2007-1004193
  6. Freeman ML, Nelson DB, Sherman S, et al. Complications of endoscopic biliary sphincterotomy. N Engl J Med 1996;335:909-918. https://doi.org/10.1056/NEJM199609263351301
  7. Hui CK, Lai KC, Yuen MF, Wong WM, Lam SK, Lai CL. Does withholding aspirin for one week reduce the risk of postsphincterotomy bleeding? Aliment Pharmacol Ther 2002;16:929-936. https://doi.org/10.1046/j.1365-2036.2002.01251.x
  8. Kimchi NA, Broide E, Scapa E, Birkenfeld S. Antiplatelet therapy and the risk of bleeding induced by gastrointestinal endoscopic procedures: a systematic review of the literature and recommendations. Digestion 2007;75:36-45. https://doi.org/10.1159/000101565
  9. Eisen GM, Baron TH, Dominitz JA, et al. Guideline on the management of anticoagulation and antiplatelet therapy for endoscopic procedures. Gastrointest Endosc 2002;55:775-779. https://doi.org/10.1016/S0016-5107(02)70402-1
  10. Zuckerman MJ, Hirota WK, Adler DG, et al. ASGE guideline: the management of low-molecular-weight heparin and nonaspirin antiplatelet agents for endoscopic procedures. Gastrointest Endosc 2005;61:189-194. https://doi.org/10.1016/S0016-5107(04)02392-2
  11. Ono S, Fujishiro M, Hirano K, et al. Retrospective analysis on the management of anticoagulants and antiplatelet agents for scheduled endoscopy. J Gastroenterol 2009;44:1185-1189. https://doi.org/10.1007/s00535-009-0127-6
  12. Veitch AM, Baglin TP, Gershlick AH, Harnden SM, Tighe R, Cairns S. Guidelines for the management of anticoagulant and antiplatelet therapy in patients undergoing endoscopic procedures. Gut 2008;57:1322-1329. https://doi.org/10.1136/gut.2007.142497